α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain
- PMID: 37047495
- PMCID: PMC10095066
- DOI: 10.3390/ijms24076524
α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain
Abstract
Nicotinic acetylcholine receptors (nAChRs) present as many different subtypes in the nervous and immune systems, muscles and on the cells of other organs. In the immune system, inflammation is regulated via the vagus nerve through the activation of the non-neuronal α7 nAChR subtype, affecting the production of cytokines. The analgesic properties of α7 nAChR-selective compounds are mostly based on the activation of the cholinergic anti-inflammatory pathway. The molecular mechanism of neuropathic pain relief mediated by the inhibition of α9-containing nAChRs is not fully understood yet, but the role of immune factors in this process is becoming evident. To obtain appropriate drugs, a search of selective agonists, antagonists and modulators of α7- and α9-containing nAChRs is underway. The naturally occurring three-finger snake α-neurotoxins and mammalian Ly6/uPAR proteins, as well as neurotoxic peptides α-conotoxins, are not only sophisticated tools in research on nAChRs but are also considered as potential medicines. In particular, the inhibition of the α9-containing nAChRs by α-conotoxins may be a pathway to alleviate neuropathic pain. nAChRs are involved in the inflammation processes during AIDS and other viral infections; thus they can also be means used in drug design. In this review, we discuss the role of α7- and α9-containing nAChRs in the immune processes and in pain.
Keywords: Ly6/uPAR proteins; Lynx1; SLURP-1; anti-inflammatory pathway; chronic pain; nicotinic acetylcholine receptors; viral infection; α-conotoxins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.ACS Chem Neurosci. 2022 Mar 2;13(5):624-637. doi: 10.1021/acschemneuro.1c00747. Epub 2022 Feb 15. ACS Chem Neurosci. 2022. PMID: 35167270 Free PMC article.
-
Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins.Toxins (Basel). 2015 May 14;7(5):1683-701. doi: 10.3390/toxins7051683. Toxins (Basel). 2015. PMID: 26008231 Free PMC article. Review.
-
α9-containing nicotinic acetylcholine receptors and the modulation of pain.Br J Pharmacol. 2018 Jun;175(11):1915-1927. doi: 10.1111/bph.13931. Epub 2017 Jul 30. Br J Pharmacol. 2018. PMID: 28662295 Free PMC article. Review.
-
Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.Pharmacol Res. 2023 Jul;193:106801. doi: 10.1016/j.phrs.2023.106801. Epub 2023 May 24. Pharmacol Res. 2023. PMID: 37236412 Review.
-
α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia.Mol Pain. 2014 Oct 2;10:64. doi: 10.1186/1744-8069-10-64. Mol Pain. 2014. PMID: 25274008 Free PMC article.
Cited by
-
Inhibition of nicotinic acetylcholine receptors by oligoarginine peptides and polyamine-related compounds.Front Pharmacol. 2023 Dec 15;14:1327603. doi: 10.3389/fphar.2023.1327603. eCollection 2023. Front Pharmacol. 2023. PMID: 38169863 Free PMC article.
-
Virally mediated enhancement of efferent inhibition reduces acoustic trauma in wild-type murine cochleas.Mol Ther Methods Clin Dev. 2025 Mar 21;33(2):101455. doi: 10.1016/j.omtm.2025.101455. eCollection 2025 Jun 12. Mol Ther Methods Clin Dev. 2025. PMID: 40236498 Free PMC article.
-
Enteric Nervous System: Identification of a Novel Neuronal Sensory Network in the Duodenal Epithelium.J Histochem Cytochem. 2023 Nov;71(11):601-630. doi: 10.1369/00221554231203038. Epub 2023 Oct 4. J Histochem Cytochem. 2023. PMID: 37791513 Free PMC article.
-
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis.Neurochem Res. 2025 Jan 27;50(2):85. doi: 10.1007/s11064-025-04336-8. Neurochem Res. 2025. PMID: 39869278 Review.
-
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease.Cells. 2024 Mar 7;13(6):474. doi: 10.3390/cells13060474. Cells. 2024. PMID: 38534318 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources